BioNexus Gene Lab removes eight directors, appoints four new directors and new CEO

BioNexus Gene Lab Corp

Stockholders owning 50.1% (17,792,663 shares) approved removal of eight directors and appointment of four new directors via written consent.
Eight prior directors removed: Yeat Min Fong, Chi Yuen Leong, Yee Meng Wong, Teng Fook Fong, Chee Keong Yap, Chak Hua Yew, Boon Teong Teoh, and Chai Ping Lin.
New directors: Koon Wai Wong, Wei Foong Lim, Muhammad Azrul bin Abdul Hamid, and Chee Keong Yap (independent); terms expire at 2024 annual meeting.
Su-Leng Tan Lee appointed CEO and Secretary effective Dec 11, 2023; two-year employment agreement with non-compete for 24 months after termination.
Board committees reconstituted: Audit (Chair: Chee Keong Yap), Compensation (Chair: Muhammad Azrul bin Abdul Hamid), Nomination & Corp Gov (Chair: Muhammad Azrul bin Abdul Hamid).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.